Chemical linkers in antibody-drug conjugates (ADCs) /
The covalent conjugation of potent cytotoxic agents to monoclonal antibodies, known as antibody-drug conjugates (ADCs) is a powerful approach in the field of targeted treatment of cancer. Clearly, both monoclonal antibody and cytotoxic payload are crucial elements in determining the clinical value o...
| Other Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Cambridge, UK :
Royal Society of Chemistry,
2022
Croydon : [2022] |
| Series: | RSC drug discovery series ;
81 |
| Subjects: |
Internet
This item is not available through BorrowDirect. Please contact your institution’s interlibrary loan office for further assistance.Stanford University
| Call Number: |
INTERNET RESOURCE |
|---|
Duke University
| Call Number: |
ISIL:US-NCD |
|---|